Bebe Stores, Inc.
BEBE
$0.66
$0.000.00%
| Weiss Ratings | BEBE - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | BEBE - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | BEBE - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.78 | |||
| Price History | BEBE - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -7.99% | |||
| 30-Day Total Return | -26.67% | |||
| 60-Day Total Return | -37.14% | |||
| 90-Day Total Return | -60.50% | |||
| Year to Date Total Return | -33.33% | |||
| 1-Year Total Return | -36.67% | |||
| 2-Year Total Return | -61.87% | |||
| 3-Year Total Return | -79.40% | |||
| 5-Year Total Return | -56.39% | |||
| 52-Week High % Change | -87.99% | |||
| 52-Week Low % Change | 1.54% | |||
| Price | BEBE - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $5.50 | |||
| 52-Week Low Price | $0.65 | |||
| 52-Week Low Price (Date) | Mar 31, 2025 | |||
| 52-Week High Price (Date) | Nov 18, 2024 | |||
| Valuation | BEBE - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 8.50M | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -- | |||
| Earnings Per Share Growth | -- | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -- | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.66 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | BEBE - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | -- | |||
| Dividend Yield | 12.12% | |||
| Div. Per Share (Most Recent) | $2.00 | |||
| Dividend Per Share (TTM) | $0.08 | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | $2.00 | |||
| Company Info | BEBE - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 415 251 3355 | |||
| Address | 550 Wisconsin Street San Francisco, CA 94107 | |||
| Website | www.bebe.com | |||
| Country | United States | |||
| Year Founded | 1976 | |||
| Profitability | BEBE - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -21.89% | |||
| Profit Margin | -189.53% | |||
| Management Effectiveness | BEBE - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -9.07% | |||
| Return on Equity | -- | |||
| Income Statement | BEBE - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 65.72M | |||
| Total Revenue (TTM) | 65.72M | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | 15.36M | |||
| EBITDA (TTM) | -7.90M | |||
| EBIT (TTM) | -14.39M | |||
| Net Income (TTM) | -124.56M | |||
| Net Income Avl. to Common (TTM) | -124.56M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 88.96% | |||
| EPS Diluted (TTM) | -15.43 | |||
| EPS Diluted Growth (Q YOY) | 76.13% | |||
| Balance Sheet | BEBE - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 16.84M | |||
| Cash Per Share (Q) | $2.07 | |||
| Total Current Assets (Q) | 28.05M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -9.47M | |||
| Current Ratio (Q) | 0.734 | |||
| Book Value Per Share (Q) | -- | |||
| Total Assets (Q) | -- | |||
| Total Current Liabilities (Q) | 38.23M | |||
| Total Debt (Q) | -- | |||
| Total Liabilities (Q) | -- | |||
| Total Common Equity (Q) | -9.47M | |||
| Cash Flow | BEBE - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 22.88M | |||
| Cash from Financing (TTM) | 15.03M | |||
| Net Change in Cash (TTM) | -49.96M | |||
| Levered Free Cash Flow (TTM) | -607.60K | |||
| Cash from Operations (TTM) | -87.88M | |||
